Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea. It provides cephalosporin antibiotic, antipsychotic, cardiovascular, and nutrition products. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. is a subsidiary of KT&G Corporation.

Yungjin Pharm. Co., Ltd.

영진약품주식회사 manufactures pharmaceuticals and health products. The company engages in research and development and offers medical devices and cosmetics.

0035

KR:CO:YUNGJIN

영진약품주식회사

Last Close

2,080.00

22/11 06:30

Market Cap

398.71B

Beta: -

Volume Today

109.82K

Avg: -